Conditional Architecture

Google DeepMind has released AlphaGenome 2, shifting DNA variant effect prediction from tissue-level averages to individual cell types and states, identifying nearly twice as many expression-altering variants as the previous best model. Built on a conditional architecture trained on over 107 million single-cell profiles with cross-modal imputation support, it is now available via API for non-commercial research.